Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
Thrower SL, James L, Hall W, Green KM, Arif S, Allen JS, Van-Krinks C, Lozanoska-Ochser B, Marquesini L, Brown S, Wong FS, Dayan CM, Peakman M.
Clin Exp Immunol. 2009 Feb;155(2):156-65. Epub 2008 Nov 20.PMID: 19040615 [PubMed - indexed for MEDLINE]Related articles